Agilus 120 mg, Pulver zur Herstellung einer Injektionslösung - 6 Swissmedic Key 69083001 Registration Holder Norgine AG Name Agilus 120 mg, Pulver zur Herstellung einer Injektionslösung Date of registration 27.06.2024 Introduction of Sequence 27.06.2024 ATC-Classification Dantrolene (M03CA01) Revision date WHO WHO-DDD Valid until 26.06.2029 Index Therapeuticus (BSV) Show package size 6 Index Therapeuticus (Swissmedic) 01.12. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680690830014 Medication Code Synthetika Pharmacode Disponibility
Composition dantrolenum natricum hemiheptahydricum 120 mg, hydroxypropylbetadexum 3530 mg, macrogolum 3350, pro vitro corresp. natrium 6.9 mg. Packungsbestandteile Galenic Form Dry substance Excipiens Active Agent Dose Dantrolenum Natricum Hemiheptahydricum 120 mg
Inactive agents Dose Hydroxypropylbetadexum 3530 mg Macrogol 3350
Source Data was imported : 04.07.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
